Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
3993 PKSHA Technology
- 3835
- +40+1.05%
20min DelayMarket Closed Dec 30 15:30 JST
122.52BMarket Cap56.72P/E (Static)
3875High3765Low412.50KVolume3800Open3795Pre Close1.59BTurnover685052wk High2.81%Turnover Ratio31.95MShares237652wk Low67.6EPS TTM56.21BFloat Cap8365Historical High56.72P/E (Static)14.66MShs Float1329Historical Low67.61EPS LYR2.90%Amplitude--Dividend TTM3.69P/B100Lot Size--Div YieldTTM
PKSHA Technology Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 21.46%16.89B | 23.00%4.26B | 20.80%3.86B | 20.84%13.91B | 27.36%3.77B | 21.38%3.48B | 14.35%3.46B | 20.40%3.2B | 31.89%11.51B | 13.15%2.96B |
| Cost of revenue | 8.29%8.36B | 3.73%1.9B | 13.04%1.85B | 33.71%7.72B | 87.47%2.7B | 7.50%1.56B | 18.98%1.83B | 21.39%1.63B | 12.33%5.77B | -4.52%1.44B |
| Gross profit | 37.88%8.53B | 44.59%2.36B | 28.91%2.02B | 7.89%6.19B | -29.44%1.07B | 35.64%1.92B | 9.57%1.63B | 19.39%1.56B | 59.93%5.74B | 37.12%1.52B |
| Operating expense | -2.22%5.3B | -15.93%1.03B | 17.16%1.23B | 29.91%5.42B | 35.42%1.59B | 50.24%1.56B | 22.55%1.22B | 8.99%1.05B | 42.01%4.17B | 32.59%1.17B |
| Selling and administrative expenses | 1.01%5.38B | -9.13%1.12B | 16.39%1.23B | --5.33B | ---- | ---- | --1.24B | --1.06B | ---- | ---- |
| -General and administrative expense | 1.01%5.38B | -9.13%1.12B | 16.39%1.23B | --5.33B | ---- | ---- | --1.24B | --1.06B | ---- | ---- |
| Other operating expenses | -91.32%32.27M | -66.10%757K | -77.82%1.22M | --371.88M | ---- | ---- | --2.23M | --5.48M | ---- | ---- |
| Total other operating income | -58.13%119.07M | 452.90%97.97M | -77.54%3.17M | --284.35M | ---- | ---- | --17.72M | --14.1M | ---- | ---- |
| Operating profit | 319.60%3.24B | 224.97%1.33B | 52.91%786.51M | -50.75%771.15M | -246.50%-512.79M | -4.55%359.42M | -16.72%410.17M | 48.33%514.35M | 140.79%1.57B | 54.81%350.04M |
| Net non-operating interest income (expenses) | 124.13%83.89M | 92.90%-21.69M | 103.46%2.43M | -424.99%-347.66M | -2,221.12%-319.97M | 2,120.20%347.84M | -1,676.08%-305.33M | -289.42%-70.2M | -25.19%-66.22M | 23.78%-13.79M |
| Non-operating interest income | 57.16%122.71M | -93.80%298K | -0.17%34.91M | --78.08M | ---- | ---- | --4.81M | --34.97M | ---- | ---- |
| Non-operating interest expense | -90.88%38.83M | -92.91%21.99M | -69.11%32.49M | 895.49%425.74M | 3,923.97%398.05M | -3,721.94%-387.48M | 2,806.59%310.13M | 814.00%105.17M | 59.50%42.77M | -14.47%9.89M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -10.08%23.45M | -40.30%3.89M |
| Net investment income | 73.83%65.39M | 0 | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 102.77%999K | 3.39M | ||||||||
| Income from associates and other participating interests | 134.41%23.69M | -8.89%57.65M | 286.14%69.16M | -422.37%-68.83M | 1,332.54%1.28B | -1,424.80%-1.37B | 1,878.39%63.28M | -288.43%-37.16M | 27.62%-13.18M | -9,777.78%-103.65M |
| Special income (charges) | 91.33%-1.31M | 98.97%-103K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -91.33%1.31M | -98.97%103K |
| Other non-operating income (expenses) | 93.09%-3.08M | -72.63%-4.59M | ||||||||
| Income before tax | 842.66%3.34B | 714.23%1.37B | 110.84%858.1M | -77.10%354.66M | 105.42%475.13M | -241.10%-695.58M | -64.72%168.12M | 17.07%406.99M | 197.16%1.55B | 17.26%231.3M |
| Income tax | 227.45%1.24B | 187.04%505.95M | 52.99%314.84M | -43.46%378.85M | -101.09%-1.53M | -100.73%-1.68M | 25.20%176.27M | 29.68%205.79M | 81.25%670.08M | 59.35%140.01M |
| Net income | 8,792.46%2.1B | 10,693.40%862.94M | 170.01%543.26M | -102.75%-24.19M | 422.13%476.66M | -364.46%-693.9M | -102.43%-8.15M | 6.47%201.2M | 480.16%878.43M | -16.54%91.29M |
| Net income continuous operations | 8,792.46%2.1B | 10,693.40%862.94M | 170.01%543.26M | -102.75%-24.19M | 422.13%476.66M | -364.46%-693.9M | -102.43%-8.15M | 6.47%201.2M | 480.16%878.43M | -16.54%91.29M |
| Noncontrolling interests | 109.01%2.6M | 219.32%4.35M | 76.91%-1.87M | -169.12%-28.9M | -546.92%-54.23M | 252.52%37.06M | -132.51%-3.64M | -201.68%-8.09M | 249.04%41.82M | 49.18%12.13M |
| Net income attributable to the company | 44,478.73%2.1B | 19,167.09%858.59M | 160.46%545.13M | -99.44%4.71M | 570.68%530.88M | -390.22%-730.97M | -101.39%-4.5M | 15.63%209.3M | 500.02%836.61M | -21.82%79.16M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 44,478.73%2.1B | 19,167.09%858.59M | 160.46%545.13M | -99.44%4.71M | 570.68%530.88M | -390.22%-730.97M | -101.39%-4.5M | 15.63%209.3M | 500.02%836.61M | -21.82%79.16M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 45,086.67%67.78 | 18,573.33%27.71 | 157.52%17.64 | -99.45%0.15 | 573.26%17.37 | -390.53%-23.94 | -101.41%-0.15 | 15.51%6.85 | 497.82%27.38 | -22.52%2.58 |
| Diluted earnings per share | 44,973.33%67.61 | 18,520.00%27.63 | 164.76%17.58 | -99.44%0.15 | 579.13%17.0462 | -399.25%-23.94 | -101.45%-0.15 | 15.48%6.64 | 502.49%26.57 | -21.56%2.51 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
